ORIGINAL ARTICLE: PDF OnlyThe prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy; A comparison with the fatigue experienced by healthy individualsIrvine, Diane R.N., M.H.Sc.; Vincent, Leslie R.N., M.Sc.A.; Graydon, Jane E. R.N., Ph.D.; Bubela, Natalie R.N., M.Sc.A.; Thompson, Leslee R.N., M.Sc.N.Author Information Diane Irvine is a doctoral candidate, Department of Health Administration, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Leslie Vincent is Program Director, Nursing Oncology/Palliative Care; Oncology Clinical Nurse Specialist, Mount Sinai Hospital; and Associate Professor, Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada. Jane E. Graydon is Associate Professor and Chair, Graduate Department of Nursing Science, University of Toronto, Toronto, Ontario, Canada. Natalie Bubela is Director of Nursing Services, Salvation Army Scarborough Grace Hospital, Scarborough, Ontario, and Associate Member, School of Graduate Studies, Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada. Leslee Thompson is Vice President of Patient Care Service, Royal Alexandra Health Care Corporation, Edmonton, Alberta, Canada. Cancer Nursing: October 1994 - Volume 17 - Issue 5 - p 367-378 Buy Abstract Fatigue can be a prevalent and serious problem for the individual with cancer and can negatively impact on the individual's quality of life. Little is known about the prevalence of clinical fatigue among patients with cancer and how the fatigue cancer patient's experience compares with the fatigue people experience as a function of their normal daily activities. This study, which utilized a control group, investigated the prevalence of fatigue among patients receiving treatment with radiotherapy (n = 54) and chemotherapy (n = 47) over two measurement points. The level of fatigue experienced by cancer patients was compared with the level of fatigue experienced by apparently healthy auxiliary staff (n = 53) working at three cancer treatment facilities. There were no differences in the mean level of fatigue experienced by cancer patients and the mean level experienced by healthy controls before the start of cancer treatment. © Lippincott-Raven Publishers.